Induced Pluripotent Stem Cells (iPSCs)
Quick Facts
| Feature | Information |
|---|---|
| Cell Type | Induced Pluripotent Stem Cells |
| Species | Human, Mouse, Rat |
| Tissue of Origin | Reprogrammed Somatic Cells |
| Growth Mode | Adherent Colonies |
| Morphology | Flat, compact colonies with smooth borders |
| Recommended Medium | mTeSR Plus, Essential 8 (E8), or equivalent feeder-free stem cell medium |
| Incubation Conditions | 37°C, 5% CO₂, ≥95% humidity |
| Proliferation | Unlimited |
| Pluripotency State | Typically Primed (Human) |
| Major Applications | Disease Modeling, Regenerative Medicine, Gene Editing, Organoids, Personalized Medicine, Drug Discovery |
Overview
Induced Pluripotent Stem Cells (iPSCs) are somatic cells that have been reprogrammed back into a pluripotent state through the forced expression of defined transcription factors. Like embryonic stem cells, iPSCs possess unlimited self-renewal capacity and can differentiate into derivatives of all three embryonic germ layers.
Unlike embryonic stem cells, iPSCs are generated from adult tissues without the use of embryos, allowing the creation of patient-specific pluripotent cell lines for disease modeling, regenerative medicine, and personalized therapeutics.
Biological Characteristics
Self-Renewal
Under appropriate culture conditions, iPSCs proliferate indefinitely while maintaining pluripotency.
Pluripotency
Induced pluripotent stem cells can generate derivatives of:
- Ectoderm
- Mesoderm
- Endoderm
Patient Specificity
Because iPSCs retain the donor's genetic background, they provide an ideal platform for personalized disease modeling and precision medicine.
Historical Background
Induced pluripotent stem cells were first generated by Shinya Yamanaka and colleagues in 2006 through the introduction of four transcription factors into somatic cells. This groundbreaking discovery revolutionized regenerative medicine and earned Shinya Yamanaka the 2012 Nobel Prize in Physiology or Medicine.
The Yamanaka Factors
The classical reprogramming factors are collectively known as OSKM:
- OCT4
- SOX2
- KLF4
- c-MYC
These factors reset the epigenetic state of differentiated cells, restoring pluripotency.
Growth Characteristics
| Characteristic | Description |
|---|---|
| Growth Mode | Adherent colonies |
| Colony Morphology | Flat, compact colonies with smooth edges |
| Doubling Time | Approximately 24-36 hours |
| Passaging Frequency | Every 4-7 days |
| Pluripotency State | Typically Primed (Human) |
Healthy colonies exhibit:
- High nucleus-to-cytoplasm ratio
- Dense cell packing
- Smooth colony borders
- Uniform morphology
Culture Conditions
Common Starting Cell Types
Frequently reprogrammed cell sources include:
- Dermal fibroblasts
- Peripheral blood mononuclear cells (PBMCs)
- Keratinocytes
- Urine-derived cells
- Dental pulp cells
- T lymphocytes
- Monocytes
Culture System
Most laboratories use feeder-free culture systems with matrices such as:
- Matrigel
- Vitronectin
- Laminin-521
Recommended Medium
Common media include:
- mTeSR Plus
- Essential 8 (E8)
- TeSR-E8
A typical feeder-free culture system consists of:
Matrigel + mTeSR Plus
Incubation Conditions
| Parameter | Value |
|---|---|
| Temperature | 37°C |
| CO₂ | 5% |
| Relative Humidity | ≥95% |
| Medium Change | Daily |
Reprogramming Methods
Current approaches include:
Integrating Methods
- Retroviral vectors
- Lentiviral vectors
Non-Integrating Methods
Preferred for research and clinical applications:
- Sendai virus
- Episomal vectors
- mRNA reprogramming
Among these, Sendai virus is one of the most widely used because it provides high efficiency without genomic integration.
Passaging
Routine passaging commonly uses:
- EDTA
- Accutase
The ROCK inhibitor Y-27632 is frequently added after single-cell dissociation to improve cell survival.
Molecular Characteristics
Core Pluripotency Markers
| Marker | Function |
|---|---|
| OCT4 | Pluripotency maintenance |
| SOX2 | Self-renewal |
| NANOG | Maintenance of pluripotency |
Surface Markers
| Marker | Significance |
|---|---|
| SSEA-4 | Human pluripotent stem cell marker |
| TRA-1-60 | Undifferentiated cells |
| TRA-1-81 | Undifferentiated cells |
| EpCAM | Epithelial marker |
Quality Control
Routine characterization should include:
- Colony morphology
- OCT4, SOX2, and NANOG expression
- TRA-1-60 and SSEA-4 staining
- Flow cytometry
- Karyotyping
- Mycoplasma testing
- Sterility testing
- Pluripotency verification
Differentiation Potential
Ectoderm
Common derivatives include:
- Neurons
- Astrocytes
- Oligodendrocytes
Representative markers include:
- PAX6
- Nestin
- SOX1
Mesoderm
Common derivatives include:
- Cardiomyocytes
- Endothelial cells
Representative markers include:
- Brachyury
- NKX2.5
Endoderm
Common derivatives include:
- Hepatocyte-like cells
- Pancreatic β cells
Representative markers include:
- SOX17
- FOXA2
Applications
Induced pluripotent stem cells are extensively used for:
- Disease modeling
- Regenerative medicine
- Drug discovery
- Personalized medicine
- Organoid generation
- Gene editing
- Functional genomics
- Toxicology
- Cell therapy research
- Developmental biology
Disease Modeling
Patient-derived iPSCs have transformed the study of numerous diseases, including:
- Alzheimer's disease
- Parkinson's disease
- Amyotrophic lateral sclerosis (ALS)
- Huntington's disease
- Autism spectrum disorders
- Cardiomyopathies
- Diabetes mellitus
- Rare genetic disorders
Organoid Research
iPSCs are widely used to generate:
- Brain organoids
- Cortical organoids
- Midbrain organoids
- Liver organoids
- Kidney organoids
- Intestinal organoids
- Retinal organoids
These models closely recapitulate human development and disease.
Gene Editing
Common genome engineering technologies include:
- CRISPR-Cas9
- Base editing
- Prime editing
Applications include:
- Mutation correction
- Isogenic control generation
- Functional genomics
- Disease modeling
Advantages
- Patient-specific cells
- Unlimited expansion
- Human genetic background preserved
- Broad differentiation potential
- Fewer ethical concerns than hESCs
- Excellent platform for precision medicine
Limitations
- Variable reprogramming efficiency
- Epigenetic memory
- Genetic instability during prolonged culture
- Time-consuming generation
- Expensive culture systems
- Differentiation variability
References
- Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse fibroblasts. Cell (2006).
- Takahashi K et al. Induction of pluripotent stem cells from adult human fibroblasts. Cell (2007).
- Yu J et al. Induced pluripotent stem cell lines derived from human somatic cells. Science (2007).
- Stadtfeld M, Hochedlinger K. Induced pluripotency: history, mechanisms, and applications. Genes & Development (2010).